Mari Yuasa-Ishigami
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring.
Journal: Molecular pharmacology
Published: May 09, 2023
CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.
Journal: The Journal of biological chemistry
Published: December 10, 2020
Development of Androgen-Antagonistic Coumarinamides with a Unique Aromatic Folded Pharmacophore.
Journal: International journal of molecular sciences
Published: July 09, 2020
Chemical Screening of Nuclear Receptor Modulators.
Journal: International journal of molecular sciences
Published: July 01, 2020
Structural development of N-(4-phenoxyphenyl)benzamide derivatives as novel SPAK inhibitors blocking WNK kinase signaling.
Journal: Bioorganic & medicinal chemistry letters
Published: June 04, 2020
Prostaglandin E2 and its receptor EP2 trigger signaling that contributes to YAP-mediated cell competition.
Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: January 11, 2020
Characterization of a novel compound that promotes myogenesis via Akt and transcriptional co-activator with PDZ-binding motif (TAZ) in mouse C2C12 cells.
Journal: PloS one
Published: November 13, 2019
Structural development of a type-1 ryanodine receptor (RyR1) Ca2+-release channel inhibitor guided by endoplasmic reticulum Ca2+ assay.
Journal: European journal of medicinal chemistry
Published: March 22, 2019
Class IIb HDAC Inhibition Enhances the Inhibitory Effect of Am80, a Synthetic Retinoid, in Prostate Cancer.
Journal: Biological & pharmaceutical bulletin
Published: March 05, 2019
Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents.
Journal: Bioorganic & medicinal chemistry
Published: August 04, 2018
Last Updated: 09/26/2026